Blog
RSS FeedPosted by Michael Wonder on 18 Jul 2017
Roche’s Ocrevus (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia
17 July 2017 - Second approval after the US for Ocrevus as the first and only approved treatment for people with ...
Posted by Michael Wonder on 13 Jun 2017
Generic and biosimilar prescription medicines, 2016
13 June 2017 -The generic and biosimilar prescription medicines: TGA annual summary 2016 publication provides details of all generic and ...
Posted by Michael Wonder on 02 May 2017
MSD plans 2017 launch of Renflexis (infliximab) in Australia
1 May 2017 - Latest MSD biosimilar secures TGA approval. ...
Posted by Michael Wonder on 20 Apr 2017
Therapeutic Goods Administration approves Afstyla - CSL Behring's novel recombinant haemophilia A treatment
19 April 2017 - In clinical trials, patients undergoing prophylaxis with Afstyla experienced a median annualised spontaneous bleeding rate of ...
Posted by Michael Wonder on 18 Apr 2017
Submissions received and TGA response: orphan drug program
18 April 2017 - The TGA would like to thank respondents who provided submissions in response to the October 2016 ...
Posted by Michael Wonder on 12 Feb 2017
TGA approval timelines for new cancer medicines
13 February 2017 - The publication of submission dates in the TGA's Annual Report for 2016 enables more insightful analysis ...
Posted by Michael Wonder on 01 Feb 2017
Diabetes drug that cuts sugar will also reduce heart problems
2 February 2017 - Diabetes will no longer be a death sentence for many sufferers, with a drug often prescribed ...
Posted by Michael Wonder on 10 Jan 2017
Australian approval for drug that 'melts' leukaemia
10 January 2017 - A new anti-cancer drug with the power to ‘melt away’ certain advanced forms of chronic lymphocytic ...
Posted by Michael Wonder on 22 Dec 2016
TGA approves new lung cancer drug osimertinib for patients dealt cruel double blow
23 December 2016 - Elly Calabia doesn't talk about survival rates and life expectancy with her oncologist. ...
Posted by Michael Wonder on 20 Dec 2016
TGA approves new uses for Janssen's Imbruvica
20 December 2016 - The TGA has approved the use of ibrutinib for first-line use in patients with chronic lymphocytic ...
Posted by Michael Wonder on 06 Dec 2016
Antizol approved by TGA
5 December 2016 - The TGA has approved a new medicine from AFT Pharmaceuticals. ...
Posted by Michael Wonder on 05 Dec 2016
Nocdurna approved by TGA
5 December 2016 - The TGA has approved a new indication for Ferring's desmopressin acetate. ...
Posted by Michael Wonder on 05 Dec 2016
TGA approves AbbVie's Technivie
5 December 2016 - The TGA has approved another AbbVie combination product for use by patients with chronic hepatitis C ...
Posted by Michael Wonder on 23 Nov 2016
TGA approves extended use of Harvoni
23 November 2016 - The TGÅ has approved the use of Harvoni in additional genotypes. ...
Posted by Michael Wonder on 23 Nov 2016
Belsomra finally approved by TGA
23 November 2016 - The TGA has approved MSD's orexin receptor antagonist. ...